All news
European Trio Council Recognises Imperative of Patient Expertise in Research
22 September 2021DiCE Supports Principles of Successful Patient Involvement in Cancer Research as Outlined by The Trio Presidency of the European Council
...
Liver Cancer Awareness Month – Join us in October!
21 September 2021Come and join our activities and help raise awareness for Liver Cancer in October!
...
Finnish Governmental Decision on National Colorectal Cancer Screening Positive Step Towards Saving Lives
21 September 2021DiCE speaks with Jenni Tamminen Executive Director Colores about the positive Finnish CRC screening decision
...
Organisational Announcement – Sincere Expression of Thanks and Congratulations!
16 September 2021Digestive Cancers Europe would like to inform you of the following organisational updates. Firstly, for our Board of Directors: Board Member Iga Ra...
Member Participation Requested – Survey on Patient Organisations’ Impact on Healthcare Systems
26 July 2021Digestive Cancers Europe Members are invited to take part in this survey to help reinforce the patient voice in healthcare systems
...
Keeping up Momentum on European Policy Advocacy
26 July 2021Digestive Cancers Europe – An update on our advocacy work with the European Institutions for H2 2021
...
For Patient Experts – New Online Course Available on Academic Publishing Practices
26 July 2021This four one-hour modular course can get patients on the right track for publishing in academic publications
...
Update in Science Masterclass Explores Personalising Treatment Strategies in Digestive Cancers
23 July 2021Update in Science Masterclass Explores Personalising Treatment Strategies in Digestive Cancers
...
Event on Colorectal Cancer Screening and COVID-19 – Materials Available
23 July 2021June 22 – Digestive Cancers Europe was pleased to welcome over 100 participants to our event that assessed the impact of COVID-19 on colorect...
Immunotherapy Drug Combination for Treating Metastatic Colorectal Cancer Approved in the EU
30 June 2021Nivolumab & ipilumab combination approved by the EC for MSI-H or dMMR patients with mCRC broadens treatment options
...